AI Article Synopsis
- This study looked at how safe and effective a laser surgery called HoLEP is for men who still have problems after earlier prostate surgery (TURP).
- They compared two groups of patients: one group had the earlier surgery and then HoLEP, while the other group did not have the earlier surgery.
- The results showed that having the earlier surgery didn't make the new laser surgery harder or less effective, meaning HoLEP works well even after TURP.
Article Abstract
Objectives: To prospectively evaluate safety and efficacy of holmium laser enucleation of prostate (HoLEP) for surgical treatment of recurrent symptoms due to prostatomegaly after prior transurethral resection of prostate (TURP).
Materials And Methods: We prospectively evaluated 43 patients with a history of TURP who underwent HoLEP (study group). Patients in chronological order who underwent HoLEP without prior TURP were included in the control group. We hypothesized that prior TURP would increase technical difficulties, thereby leading to a reduction in procedure efficiency by 25%. Patients' demographic, intraoperative, and postoperative data were compared, and statistical analysis was performed.
Results: Demographic data in both groups were comparable. The average interval between past TURP and HoLEP was 4.22 years. There was no difficulty in identifying the dissection plane in the study group and the difference in the procedure efficiency between the study and the control groups were statistically insignificant (0.75 ± 0.31 g/min-study group vs. 0.69 ± 0.36 g/min-control group; = 0.665). The intraoperative parameters and postoperative outcomes were comparable in both groups.
Conclusions: Prior TURP does not negatively impact the outcome of HoLEP in treating symptomatic recurrence for enlarged prostate after initial TURP.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197008 | PMC |
| http://dx.doi.org/10.4103/ua.ua_106_21 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Introduction Low testosterone (T) is linked with frailty, which predicts poor postoperative recovery across many surgical procedures. Therefore, low T may impact perioperative outcomes for surgical patients. We sought to characterize the association between low T, frailty, and perioperative outcomes in patients undergoing transurethral resection of the prostate (TURP) and laser photovaporization of the prostate (PVP).
View Article and Find Full Text PDFA Clinicopathologic Study of 1598 Ultrasound-Guided Needle Prostate Biopsies and Trends in Prostate Cancer Over a 14-Year Period.
Clin Genitourin Cancer
February 2025
Department of Pathology, Qazvin University of Medical Sciences, Qazvin, Iran. Electronic address:
Background: Prostate cancer manifests in various forms, ranging from occult and localized to metastatic disease. Analyzing prostate biopsies offers insights into histopathological characteristics, enhancing disease understanding and management.
Methods: This 14-year study reviewed ultrasound-guided needle prostate biopsies, collecting data via questionnaires and medical records, focusing on Gleason group, tumor involvement percentage, and predicted cancer stage.
Factors Contributing to Early Recovery of Urinary Continence Following Radical Prostatectomy: A Narrative Review.
J Clin Med
November 2024
Department of Urology, Hospital Kassel, 34125 Kassel, Germany.
Stress urinary incontinence (SUI) is a common condition in patients following radical prostatectomy (RP), which has a significant impact on all aspects of quality of life and is associated with significant social stigma. The factors that improve urinary incontinence in patients following surgery remain controversial. The aim of our narrative review was to identify and synthesise the latest evidence on pre-, intra- and post-operative factors and predictors that contribute to early continence recovery after RP.
View Article and Find Full Text PDFLeiomyoma of the prostate: A case report and literature review.
Medicine (Baltimore)
November 2024
Department of Urology, The First Hospital of Jilin University, Changchun, Jilin, China.
Article Synopsis
- Prostate leiomyoma is a rare benign tumor that is often diagnosed post-surgery, with management primarily involving transurethral resection due to lack of established guidelines.
- A patient presented with urinary issues and was found to have prostate leiomyoma after imaging and prior related medical history, leading to a successful holmium laser enucleation procedure.
- Post-surgery, the patient showed no recurrence and is under regular monitoring, emphasizing the importance of patient follow-up and timely intervention for this rare condition.
Practice patterns and predictors of treatment intensification in patients with metastatic castration-sensitive prostate cancer.
Can Urol Assoc J
August 2024
The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada.
Introduction: Treatment intensification beyond androgen deprivation therapy (ADT) has shown survival benefit in patients with metastatic castration-sensitive prostate cancer (mCSPC). There is a need to better understand how these novel treatments fit in real-world practice.
Methods: Using electronic medical records and administrative data, a population-based, retrospective cohort study of patients newly diagnosed with de novo mCSPC between 2010 and 2020 in Alberta, Canada, and initiated ADT was conducted.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!